We are live on ! Find out more
IAP

Indie Asset Partners Portfolio holdings

AUM $87.8M
1-Year Est. Return 27.76%
This Fund
S&P 500
This Quarter Est. Return
+10.08%
1 Year Est. Return
+27.76%
3 Year Est. Return
+120.76%
5 Year Est. Return
+150.7%
10 Year Est. Return
AUM
$138M
AUM Growth
+$14.3M
Cap. Flow
+$3.85M
Cap. Flow %
2.79%
Top 10 Hldgs %
56.56%
Holding
136
New
10
Increased
38
Reduced
54
Closed
10

Sector Composition

Rank Sector Weight
1 Healthcare 42.37%
2 Technology 12.48%
3 Consumer Discretionary 4.69%
4 Industrials 3.41%
5 Communication Services 3.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPRX icon
1
Royalty Pharma
RPRX
$25.9B
$32.1M 23.31%
805,982
+104,659
+15% +$4.07M
LLY icon
2
Eli Lilly
LLY
$1.02T
$18.5M 13.44%
67,059
-600
-0.9% -$152K
AAPL icon
3
Apple
AAPL
$4.54T
$7.05M 5.12%
39,730
-2,861
-7% -$452K
VTIP icon
4
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$4.51M 3.28%
87,831
+52,336
+147% +$2.72M
AMZN icon
5
Amazon
AMZN
$2.92T
$3.44M 2.5%
20,620
-900
-4% -$154K
SLYV icon
6
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.89B
$2.96M 2.15%
34,941
-3,900
-10% -$333K
SCHD icon
7
Schwab US Dividend Equity ETF
SCHD
$103B
$2.74M 1.99%
101,778
+1,575
+2% +$40.9K
BLCN
8
DELISTED
Siren ETF Trust Siren NexGen Economy ETF
BLCN
$2.65M 1.92%
62,355
+2,880
+5% +$135K
META icon
9
Meta Platforms (Facebook)
META
$1.42T
$1.98M 1.44%
5,893
+64
+1% +$21.2K
ADCT icon
10
ADC Therapeutics
ADCT
$134M
$1.95M 1.42%
96,582
-829
-0.9% -$20K
MSFT icon
11
Microsoft
MSFT
$3.45T
$1.95M 1.41%
5,790
-3,259
-36% -$1.06M
IYT icon
12
iShares US Transportation ETF
IYT
$2.26B
$1.93M 1.4%
27,860
+1,580
+6% +$106K
SCHG icon
13
Schwab US Large-Cap Growth ETF
SCHG
$59.8B
$1.84M 1.34%
90,128
-6,360
-7% -$127K
VDE icon
14
Vanguard Energy ETF
VDE
$10.1B
$1.43M 1.04%
18,401
+956
+5% +$76K
PFE icon
15
Pfizer
PFE
$143B
$1.19M 0.87%
20,188
-1,443
-7% -$71.5K
SPY icon
16
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$1.16M 0.84%
2,446
+230
+10% +$106K
AMT icon
17
American Tower
AMT
$80.8B
$1.14M 0.83%
3,911
+165
+4% +$45.1K
FTCS icon
18
First Trust Capital Strength ETF
FTCS
$7.91B
$1.09M 0.79%
12,887
+465
+4% +$37.3K
SLY
19
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
$1.09M 0.79%
10,932
-150
-1% -$14.8K
ASAN icon
20
Asana
ASAN
$1.92B
$1.04M 0.76%
13,980
+1,530
+12% +$162K
SCHB icon
21
Schwab US Broad Market ETF
SCHB
$43.2B
$972K 0.71%
51,600
+702
+1% +$12.9K
SHW icon
22
Sherwin-Williams
SHW
$82.7B
$966K 0.7%
2,742
-216
-7% -$69.8K
LIT icon
23
Global X Lithium & Battery Tech ETF
LIT
$1.51B
$950K 0.69%
11,250
+60
+0.5% +$5.32K
MINT icon
24
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$16.9B
$922K 0.67%
9,080
-775
-8% -$78.8K
NVDA icon
25
NVIDIA
NVDA
$4.86T
$901K 0.65%
30,630
-8,530
-22% -$235K

Similar funds

Indie Asset Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Indie Asset Partners held 136 positions worth $138M, up 12% from $123M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Indie Asset Partners's Q4 2021 filing shows 10 new, 38 increased, 54 reduced and 10 closed positions. Its largest new stake was Global X Blockchain ETF: 7,884 shares worth $687K. The largest sale was Microsoft, an estimated $1.06M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 40% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Indie Asset Partners's largest Q4 2021 buy was Global X Blockchain ETF: 7,884 shares worth $687K.
  • Indie Asset Partners added most to Royalty Pharma in Q4 2021, an estimated $4.07M increase.
  • Indie Asset Partners's biggest Q4 2021 reduction was Microsoft, cutting an estimated $1.06M.
  • Indie Asset Partners fully exited CRISPR Therapeutics in Q4 2021, selling an estimated $326K.
  • Indie Asset Partners's ten largest holdings make up 57% of its $138M portfolio in Q4 2021.
  • Indie Asset Partners opened 10 new positions and closed 10 in Q4 2021.
  • Indie Asset Partners's portfolio value rose 12% quarter-over-quarter to $138M.

Based on Indie Asset Partners's 13F filing for Q4 2021, filed 11 Feb 2022.